-transparent.png){kind=logo}
Recent advances in immunologic techniques have allowed the generation of monoclonal antibodies against antigens on tumor cells and their normal counterparts. Monoclonal antibodies useful for diagnosing and defining subtypes of acute leukemias and neuroblastoma have been prepared, although the prognostic significance of the subtypes defined by such antibodies remains to be determined. The usefulness of these reagents for therapeutic purposes either ex vivo, in association with autologous bone marrow transplantation, or in vivo, as carriers of cytotoxic agents, is currently under investigation.
Related Publications
I Bernstein, and
J Kersey, and
R Seeger, and
R Andrews
September 1999,
Molecular biotechnology,
I Bernstein, and
J Kersey, and
R Seeger, and
R Andrews
January 2008,
Bone marrow transplantation,
I Bernstein, and
J Kersey, and
R Seeger, and
R Andrews
May 1980,
Bollettino dell'Istituto sieroterapico milanese,
I Bernstein, and
J Kersey, and
R Seeger, and
R Andrews
January 1999,
Vestnik Rossiiskoi akademii meditsinskikh nauk,
I Bernstein, and
J Kersey, and
R Seeger, and
R Andrews
January 1984,
Urologiia i nefrologiia,
I Bernstein, and
J Kersey, and
R Seeger, and
R Andrews
January 1988,
Annals of the New York Academy of Sciences,
I Bernstein, and
J Kersey, and
R Seeger, and
R Andrews
May 1972,
Das Deutsche Gesundheitswesen,
I Bernstein, and
J Kersey, and
R Seeger, and
R Andrews
January 2023,
Frontiers in immunology,
I Bernstein, and
J Kersey, and
R Seeger, and
R Andrews
June 2024,
Haematologica,
I Bernstein, and
J Kersey, and
R Seeger, and
R Andrews
January 1995,
Current topics in microbiology and immunology,
